Chemours Chooses Ontjes to Lead Investor Relations Team

Ontjes has been with Chemours since May 2016.

1 Min Read
Chemours appoints Ontjes to Industry Relations
Brandon Ontjes has been with Chemours since 2016. He has just been appointed vice president, Financial Planning & Analysis and Investor Relations.Image courtesy of Peter Dazeley / The Image Bank via Getty Images

The Chemours Co. has announced the appointment of Brandon Ontjes as vice president, Financial Planning & Analysis (FP&A) and Investor Relations.

Ontjes joined Chemours in May 2016 in technical accounting and has held positions with increasing responsibility. He served as Finance director for Chemical Solutions and more recently, Thermal & Specialized Solutions. In 2021, he was promoted to vice president leading Business Finance, Manufacturing Operations Finance, and Corporate FP&A. He now adds investor relations to his responsibilities.

“Brandon is an outstanding leader who has helped transform our financial function into a center for business insight,” said Jonathan Lock, senior vice president and chief financial officer. “His collaborative style, strong analytical skills, and ability to drive innovative solutions that advance the business will be of tremendous benefit to both Chemours and investors. I’m delighted to have him assume this critical role.”

Prior to joining Chemours, Ontjes was employed as a senior manager with Ernst & Young, holding previous positions with PricewaterhouseCoopers and Grant Thornton, LLP. He holds a Bachelor of Science degree in Accounting from Messiah University, a Master of Science in Accounting from Liberty University, and is a certified public accountant.

Chemours is a global chemistry company with market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials.

About the Author(s)

Powder Bulk Solids Staff

Established in 1983, Powder & Bulk Solids (PBS) serves industries that process, handle, and package dry particulate matter, including the food, chemical, and pharmaceutical markets.

Sign up for the Powder & Bulk Solids Weekly newsletter.

You May Also Like